Skip to main content

Advertisement

Table 1 Participant demographic and clinical characteristics

From: Characteristics of footwear worn by people with systemic lupus erythematosus: a comparison with age- and sex-matched healthy controls: a pilot study

  SLE Control
N 22 20
Sex, female, n (%) 20 (91%) 18 (90%)
Age, years 51 (15) 51 (12)
Ethnicity, n (%)
 European 13 (59%) 17 (85%)
 Māori 2 (9%) 1 (5%)
 Pacific 1 (5%) 0 (0%)
 Asian 6 (27%) 1 (5%)
 Other 0 (0%) 1 (5)
Body mass index, kg/m2 27.1 (7.0) 26.3 (5.3)
SLE disease duration, years 14.3 (10.3) -
SLEDAI-2K 12.0 (8.2) -
Medications, n (%)
 Hydroxychloroquine 12 (55%)  
 Immunosuppressive 10 (42%)  
 NSAID 10 (45%)  
 Prednisone 11 (50%)  
Comorbidities and complications of disease, n (%)
 Raynaud’s syndrome 9 (41%)  
 Lupus nephritis 3 (14%)  
 Hypertension 3 (14%)  
 Cardiovascular disease 2 (9%)  
 Dyslipidaemia 2 (9%)  
 Sjögren syndrome 2 (9%)  
 Osteoporosis 2 (9%)  
 Fibromyalgia 1 (5%)  
 Depression 2 (9%)  
  1. Values are presented as mean (SD) unless otherwise indicated. SLEDAI-2K: systematic lupus erythematosus disease activity index – 2000; NSAID: non-steroidal anti-inflammatory drug